Although many elective procedures were canceled during the course of the pandemic, the market has not been negatively affected.
Leveraging the power of technology to create a more patient-centric approach and consolidate costs is expected to play a big role.
Jennifer Fried, CEO of ExplORer Surgical, explains the stress that COVID-19 has placed on healthcare and the shift in how medical device reps are connecting with hospitals and healthcare providers.
These countries have been more successful with managing the virus than the United States and the European Union.
Ever since the advent of laparoscopic surgery some 25 years ago, payers have become wary of minimally invasive surgery. What should device manufacturers do?